Sign in
MicrobiologyProceedings of the National Academy of Sciences
Peer-reviewed journal article

The Q226L mutation can convert a highly pathogenic H5 2.3.4.4e virus to bind human-type receptors

María Ríos CarrascoiD, Ting-Hui LiniD, Xueyong ZhuiD, Alba Gabarroca GarcíaiD, Elif UsluiD, Ruonan Liang, Cindy M. SpruitiD, Mathilde RichardiD, Geert‐Jan BoonsiD, Ian A. WilsoniD, Robert P. de VriesiD

Abstract

AbstractH5Nx viruses continue to wreak havoc in avian and mammalian species worldwide. The virus distinguishes itself by the ability to replicate to high titers and transmit efficiently in a wide variety of hosts in diverse climatic environments. Fortunately, transmission to and between humans is scarce. Yet, if such an event were to occur, it could spark a pandemic as humans are immunologically naive to H5 viruses. A significant determinant of transmission to and between humans is the ability of the influenza A virus hemagglutinin (HA) protein to shift from an avian-type to a human-type receptor specificity. Here, we demonstrate that a 2016 2.3.4.4e virus HA can convert to human-type receptor binding via a single Q226L mutation, in contrast to a cleavage-modified 2016 2.3.4.4b virus HA. Using glycan arrays, x-ray structural analyses, tissue- and direct glycan binding, we show that L133a{Delta} and 227Q are vital for this phenotype. Thus, whereas the 2.3.4.4e virus HA only needs a single amino acid mutation, the modified 2.3.4.4b HA was not easily converted to human-type receptor specificity.

PDFDOI

02 /Specification & Classification

Click any tag to browse matching papers
Citations
16
FWCI
11.01
Field percentile
top 1%

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISEdwards '26Carrasco '26Kovacs '26West '21Sukhova '26Nataraj '25
82% semantic matchImmunology
Ross A. Edwards, Oluwafemi F. Adu, Egor P. Tchesnokov+10 more·bioRxiv·May 26, 2026